iShares U.S. Pharmaceuticals ETFNYSE Arca:IHE
- LAST PRICE64.38
- TODAY'S CHANGE (%)-0.45 (-0.69%)
- Bid / Lots63.17/ 24
- Ask / Lots65.58/ 23
- Open / Previous Close64.98 / 64.83
- Day Range
- 52 Week Range
- Volume41,240
- Overall Morningstar Rating3 out of 5 Starsout of 265 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IHE |
|---|---|---|
| 09:32 ET | 439 | 64.66 |
| 09:34 ET | 100 | 64.76 |
| 09:36 ET | 300 | 64.69 |
| 09:38 ET | 100 | 64.59 |
| 09:39 ET | 10304 | 64.68 |
| 09:41 ET | 300 | 64.67 |
| 09:43 ET | 600 | 64.67 |
| 09:45 ET | 200 | 64.6 |
| 09:48 ET | 200 | 64.6 |
| 09:50 ET | 100 | 64.63 |
| 09:54 ET | 200 | 64.53 |
| 09:57 ET | 200 | 64.59 |
| 09:59 ET | 200 | 64.57 |
| 10:01 ET | 500 | 64.47 |
| 10:03 ET | 100 | 64.42 |
| 10:06 ET | 350 | 64.45 |
| 10:08 ET | 500 | 64.48 |
| 10:10 ET | 400 | 64.46 |
| 10:14 ET | 100 | 64.47 |
| 10:21 ET | 200 | 64.4001 |
| 10:24 ET | 300 | 64.39 |
| 10:26 ET | 504 | 64.39 |
| 10:28 ET | 100 | 64.32 |
| 10:30 ET | 100 | 64.38 |
| 10:33 ET | 400 | 64.29 |
| 10:37 ET | 300 | 64.3 |
| 10:42 ET | 220 | 64.35 |
| 10:44 ET | 100 | 64.34 |
| 10:46 ET | 900 | 64.37 |
| 10:48 ET | 500 | 64.36 |
| 10:50 ET | 843 | 64.32 |
| 10:51 ET | 100 | 64.29 |
| 10:53 ET | 500 | 64.28 |
| 10:55 ET | 100 | 64.31 |
| 11:00 ET | 300 | 64.29 |
| 11:04 ET | 200 | 64.22 |
| 11:09 ET | 100 | 64.27 |
| 11:15 ET | 106 | 64.2399 |
| 11:20 ET | 100 | 64.27 |
| 12:00 ET | 1655 | 64.36 |
| 12:02 ET | 514 | 64.37 |
| 12:05 ET | 214 | 64.36 |
| 12:23 ET | 300 | 64.31 |
| 12:25 ET | 2100 | 64.32 |
| 12:27 ET | 154 | 64.36 |
| 12:34 ET | 100 | 64.32 |
| 01:03 ET | 900 | 64.31 |
| 01:46 ET | 165 | 64.38 |
| 01:53 ET | 3658 | 64.3343 |
| 01:57 ET | 987 | 64.3864 |
| 02:02 ET | 760 | 64.39 |
| 02:26 ET | 777 | 64.499 |
| 02:29 ET | 100 | 64.43 |
| 02:58 ET | 304 | 64.3799 |
| 03:02 ET | 200 | 64.3773 |
| 03:03 ET | 280 | 64.378 |
| 03:05 ET | 224 | 64.43 |
| 03:32 ET | 200 | 64.3899 |
| 03:38 ET | 308 | 64.4 |
| 03:59 ET | 0 | 64.38 |
Daily Premium/Discount
| Date | Daily Premium/Discount |
|---|---|
| 02/05/2024 | 0.04% |
| 02/06/2024 | 0.06% |
| 02/07/2024 | 0.05% |
| 02/09/2024 | -0.01% |
| 02/12/2024 | -0.01% |
| 02/13/2024 | 0.02% |
| 02/15/2024 | 0.00% |
| 02/16/2024 | -0.04% |
| 02/20/2024 | 0.03% |
| 02/21/2024 | -0.05% |
| 02/22/2024 | 0.02% |
| 02/23/2024 | 0.08% |
| 02/26/2024 | 0.01% |
| 02/27/2024 | 0.01% |
| 02/28/2024 | 0.05% |
| 02/29/2024 | -0.01% |
| 03/01/2024 | 0.19% |
| 03/04/2024 | 0.06% |
| 03/05/2024 | 0.04% |
| 03/06/2024 Largest Premium | 199.99% |
| 03/08/2024 | 0.02% |
| 03/11/2024 | -0.01% |
| 03/12/2024 | -0.01% |
| 03/13/2024 | 0.00% |
| 03/14/2024 | -0.04% |
| 03/15/2024 | 0.04% |
| 03/18/2024 | -0.06% |
| 03/19/2024 | -0.06% |
| 03/20/2024 | -0.02% |
| 03/21/2024 | 0.00% |
| 03/22/2024 Largest Discount | -0.21% |
| 03/25/2024 | -0.06% |
| 03/26/2024 | -0.03% |
| 03/27/2024 | -0.03% |
| 03/28/2024 | -0.03% |
| 04/01/2024 | -0.05% |
| 04/02/2024 | 0.12% |
| 04/03/2024 | 0.16% |
| 04/04/2024 | 0.04% |
| 04/05/2024 | -0.03% |
| 04/09/2024 | 0.03% |
| 04/10/2024 | 0.04% |
| 04/11/2024 | -0.06% |
| 04/12/2024 | -0.10% |
| 04/15/2024 | -0.01% |
| 04/16/2024 | 0.00% |
| 04/17/2024 | -0.03% |
| 04/18/2024 | 0.01% |
| 04/19/2024 | 0.02% |
| 04/22/2024 | -0.08% |
| 04/23/2024 | -0.03% |
| 04/24/2024 | -0.05% |
| 04/25/2024 | -0.20% |
| 04/26/2024 | 0.00% |
| 04/29/2024 | 0.01% |
| 04/30/2024 | -0.04% |
| 05/01/2024 | 0.02% |
| 05/02/2024 | 0.00% |
| 05/03/2024 | -0.03% |
| US Stock | 99.9% |
|---|---|
| Cash | 0.1% |
| Convertible | 0 |
| Non-US Bond | 0 |
| Non-US Stock | 0 |
| Other | 0 |
| Healthcare | 99.9% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 100.0% |
|---|---|
| Latin America | 0 |
| Africa | 0 |
| Asia/Oceania | 0 |
| Canada | 0 |
| Europe | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Eli Lilly and Co | Long | 24.1% | -0.49% | $155.7M |
Johnson & Johnson | Long | 21.8% | -0.49% | $141.0M |
Merck & Co Inc | Long | 5.0% | -0.49% | $32.5M |
Viatris Inc | Long | 4.6% | -0.49% | $29.5M |
Pfizer Inc | Long | 4.5% | -0.49% | $29.3M |
Royalty Pharma PLC Class A | Long | 4.5% | -0.49% | $29.0M |
Catalent Inc | Long | 4.3% | -0.49% | $27.6M |
Zoetis Inc Class A | Long | 4.2% | -0.49% | $27.0M |
Bristol-Myers Squibb Co | Long | 4.0% | -0.49% | $25.6M |
Jazz Pharmaceuticals PLC | Long | 2.9% | -0.49% | $19.0M |
Reports
- EtfValuationReport09/22/16
Morningstar ETF Report
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
- ManagedInvestmentETF04/07/24
Morningstar ETF Report
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | 3 out of 5 Stars |
| 3 Year Rating | 4 out of 5 Stars |
| 5 Year Rating | 3 out of 5 Stars |
| 10 Year Rating | 2 out of 5 Stars |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | DJ US Select Pharms TR USD |
|---|---|
Category | |
Sponsor | BlackRock Fund Advisors |
Inception | May 1, 2006 |
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
| Total Net Assets | $650.5M |
|---|---|
| Shares Out. | 10.1M |
| Net Asset Value (NAV) | $64.83 |
| Prem/Discount to NAV | 0.00% |
| P/E Ratio | 25.0 |
| Dividend Yield | 1.71% |
| Dividend per Share | 1.10 USD |
| Ex-Dividend Date | 03/21/2024 |
| Dividend Payment Date | 03/27/2024 |
| Beta | --- |
| Morningstar Investment Style | Health |
| Equity Style | Large Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.40% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.40% |